# Switzerland, Liechtenstein exports to Egypt: Trade Route Risk | Yugalinks

Understand reported exports from Switzerland, Liechtenstein to Egypt, the product routes that need a closer look, and the conditions that may affect planning.

Canonical: https://www.yugalinks.com/trade/corridor/CHE-EGY/risk

## Route overview

In 2024, Switzerland, Liechtenstein reported $1.3B in goods exports to Egypt. The overall review level is Watch.

## How to read this page

High attention means one or more conditions on these product types deserve a closer look. It is not a prediction that trade will stop or that a loss is certain. An HS6 code is the international six-digit code used to describe and compare traded goods.

## Key numbers

| Measure | Value | What it means |
| --- | ---: | --- |
| Latest reported exports | $1.3B | 2024 route total |
| Exports needing review | 19.7% | Share of route exports |
| Highest-priority products | 1 | Need the closest review |
| Products needing review | 19 | High-attention product types |
| Export volatility | 1.1 | Higher means bigger yearly swings |
| Below highest year | 29.3% | Compared with the route's best year |

## Product types to review

| Rank | HS6 | Product | Buyer-market imports | Below product high | Review level |
| ---: | --- | --- | ---: | ---: | --- |
| 1 | 300490 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | 11.9% | Stable |
| 2 | 300215 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $492.5M | 43.7% | Watch |
| 3 | 300410 | Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | $189.6M | 63% | High attention |
| 4 | 330290 | Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $144.2M | 0% | Watch |
| 5 | 710812 | Metals: gold, non-monetary, unwrought (but not powder) | $182.1M | 91.8% | Critical attention |
| 6 | 300420 | Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $103.8M | 54.9% | Watch |
| 7 | 321519 | Ink: for printing, other than black, whether or not concentrated or solid | $56.4M | 18.2% | High attention |
| 8 | 293399 | Heterocyclic compounds: n.e.c. in headings no. 2933 | $81.3M | 45.7% | Stable |
| 9 | 300439 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $120.0M | 18.2% | Stable |
| 10 | 853530 | Electrical apparatus: isolating and make-and-break switches, for a voltage exceeding 1000 volts | $41.4M | 0% | High attention |

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-29). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.